肺表面活性物质治疗足月新生儿急性呼吸窘迫综合征的临床疗效

Analysis of clinical curative effect of pulmonary surfactant in treating full-term newborns with acute respiratory distress syndrome

目的:研究肺表面活性物质治疗足月新生儿急性呼吸窘迫综合征的临床效果。方法:2013年8-11月收治急性呼吸窘迫综合征足月新生儿120例,随机分为试验组和对照组,对照组采用常规临床治疗方法,试验组在对照组的基础上应用肺表面活性物质进行治疗,观察两组的治疗效果和治疗相关情况。结果:试验组恢复总有效率96.7%,对照组恢复总有效率85%,试验组恢复情况明显优于对照组(P<0.05),试验组恢复时间也要短于对照组。结论:在足月新生儿急性呼吸窘迫综合征的治疗中应用肺表面活性物质进行治疗具有非常好的治疗效果,可以显著地提高患儿治愈的有效率,明显改善患儿的血气指标,可以进行推广和应用。

Objective:To study the clinical effect of pulmonary surfactant in treating full-term newborns with acute respiratory distress syndrome.Methods:120 full-term newborns with acute respiratory distress syndrome were selected from August to November 2013.They were randomly divided into the experimental group and the control group.The control group were given routine clinical treatment method,and the experimental group were given pulmonary surfactant treatment on the basis of the control group.The treatment effects and treatment related situations of two groups were observed.Results:The restored total effective rate of the experimental group was 96.7%;the restored total effective rate of the control group was 85%;the recovery of the experimental group was significantly better than that of the control group(P<0.05).The recovery time of the experimental group was better than that of the control group.Conclusion:Using pulmonary surfactant treatment in treating full-term newborns with acute respiratory distress syndrome has very good therapeutic effect.It can significantly improve the cure effective rate of children,significantly improved blood gas index of children,and it can be popularized and applied.